New Zealand markets closed

Cytokinetics, Incorporated (CYTK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
59.53-0.39 (-0.65%)
At close: 04:00PM EDT
59.47 -0.06 (-0.10%)
After hours: 07:21PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-530,598
-526,244
-388,955
-215,314
-127,290
Depreciation & amortisation
12,375
11,892
5,814
2,276
1,831
Stock-based compensation
78,483
72,065
47,853
26,832
17,620
Change in working capital
-3,440
3,089
-24,704
8,456
84,896
Accounts receivable
172
-1,136
56,672
-47,399
743
Accounts payable
-5,671
-3,483
4,524
1,055
-110
Other working capital
-422,568
-415,749
-310,851
-191,394
-2,109
Other non-cash items
21,625
24,830
57,676
32,384
32,459
Net cash provided by operating activities
-421,554
-414,333
-299,516
-142,522
8,943
Cash flows from investing activities
Investments in property, plant and equipment
-
-1,416
-11,335
-48,872
-11,052
Purchases of investments
-688,087
-635,211
-855,393
-525,042
-435,825
Sales/maturities of investments
795,498
875,880
604,594
426,137
250,362
Net cash used for investing activities
106,397
239,253
-262,134
-147,777
-196,515
Cash flows from financing activities
Debt repayment
-1,583
-858
-188,925
0
0
Common stock issued
257,873
164,233
0
312,049
225,108
Other financing activities
31,551
39,483
163,962
-4,449
-104
Net cash used provided by (used for) financing activities
332,285
221,317
516,166
319,980
234,124
Net change in cash
17,135
46,217
-45,484
29,681
46,552
Cash at beginning of period
103,216
67,182
112,666
82,985
36,433
Cash at end of period
120,344
113,399
67,182
112,666
82,985
Free cash flow
Operating cash flow
-421,554
-414,333
-299,516
-142,522
8,943
Capital expenditure
-
-1,416
-11,335
-48,872
-11,052
Free cash flow
-422,568
-415,749
-310,851
-191,394
-2,109